SEKISUI Diagnostics

SEKISUI Diagnostics Our product lines include clinical chemistry reagents, point-of-care tests, blood collection tube raw materials as well as enzymes and specialty biochemicals.

Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include:
• Clinical chemistry reagents
• Coagulation reagents
• Point-of-care rapid tests and immunoassay system
• Enzymes and specialty biochemicals

Balancing speed, quality, and profitability has never been more complex for point-of-care (POC) laboratories. As reimbur...
03/12/2026

Balancing speed, quality, and profitability has never been more complex for point-of-care (POC) laboratories. As reimbursement rates tighten and supply costs rise, many labs are being asked to do more with less—without compromising accuracy or compliance.

In our latest blog, we cover how POC labs can reduce waste, streamline workflows, and protect margins, all while delivering faster, more reliable results.

Keep your point-of-care testing lab profitable by adopting strategies that balance speed, quality, and cost-efficiency, ensuring sustainability and scalability in a challenging financial landscape.

Around the globe, people will be coming together to mark World Kidney Day on March 12th. https://bit.ly/4cB19dr
03/12/2026

Around the globe, people will be coming together to mark World Kidney Day on March 12th.

https://bit.ly/4cB19dr

PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections), is a challenging cond...
02/12/2026

PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections), is a challenging condition found in some children after having a recent strep infection. While it’s not overly common, it’s important to understand what the symptoms are to be sure that young patients are getting diagnosed early and that they are receiving comprehensive treatment to address these symptoms.

In our latest blog, we take a look at what the symptoms look like, how to diagnose PANDAS, and how to navigate this challenging condition.

Learn about the symptoms, diagnosis, and treatment options for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) in children.

When every diagnostic decision counts, the testing method matters. A peer reviewed article showed that the OSOM® Strep A...
02/12/2026

When every diagnostic decision counts, the testing method matters. A peer reviewed article showed that the OSOM® Strep A Test delivers the right balance of speed, accuracy, and affordability, while outperforming molecular testing.

⚡ Rapid results in minutes
🎯 Higher specificity can result in fewer false positives
💰 Lower cost without added equipment

See the full comparison here https://bit.ly/3OEJ43Z

WHX Labs World Health Expo in Dubai starts Tuesday. Visit us at stand S2.C12 to explore our diagnostic products, enzyme...
02/08/2026

WHX Labs World Health Expo in Dubai starts Tuesday. Visit us at stand S2.C12 to explore our diagnostic products, enzymes and biopharma services.

https://bit.ly/45VEgx5

Understanding PANDAS and its Association with Strep InfectionsPANDAS (Pediatric Autoimmune Neuropsychiatric Disorders As...
02/02/2026

Understanding PANDAS and its Association with Strep Infections

PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) is a pediatric disorder where children suddenly develop obsessive-compulsive disorder (OCD), tics, or both, following a streptococcal infection such as strep throat or scarlet fever. ​

Early recognition and timely evaluation are crucial for effective management and family support. Learn more!
https://bit.ly/3NGDhe3

The role of clinical diagnostics is more important than ever before, so it’s important to understand how emerging trends...
01/27/2026

The role of clinical diagnostics is more important than ever before, so it’s important to understand how emerging trends might shape the future of the industry.

Read our latest blog post covering the top five emerging trends in clinical diagnostics for 2026.

Discover the top five emerging trends in clinical diagnostics for 2026, highlighting AI integration, personalized medicine, decentralized testing, data analytics, and liquid biopsies.

The way diagnostic testing is delivered is changing rapidly. As health systems expand outpatient care and move toward de...
01/08/2026

The way diagnostic testing is delivered is changing rapidly. As health systems expand outpatient care and move toward decentralized models, point-of-care (POC) diagnostics are emerging as a key bridge between the central laboratory and the patient bedside.
This shift is not just technological, it’s structural. Clinical laboratories must now manage distributed testing environments, adapt staffing and quality systems, and maintain oversight across multiple care settings.
Read our latest blog post on the rapid evolution of point-of-care diagnostics and how clinical labs are adapting.

Symptoms of thyroid conditions may include brain fog, changes in appetite, and bowel irregularities. Identifying these s...
01/05/2026

Symptoms of thyroid conditions may include brain fog, changes in appetite, and bowel irregularities. Identifying these symptoms early can guide effective treatment. https://bit.ly/4qblV76

Happy New Year from SEKISUI Diagnostics! May 2026 bring fresh opportunities, bold innovations, and meaningful partnershi...
12/31/2025

Happy New Year from SEKISUI Diagnostics! May 2026 bring fresh opportunities, bold innovations, and meaningful partnerships. We’re excited to continue working together and making an impact. Wishing you health, happiness, and success in the year ahead.

Address

ONE Wall Street
Burlington, MA
01803

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 6pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+17816527800

Website

Alerts

Be the first to know and let us send you an email when SEKISUI Diagnostics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

Headquartered in Burlington, MA, for over 35 years Sekisui Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We have a history of innovation which includes, the first homogeneous test for LDL and the first plastic vacuum blood collection tube. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan.

Our workforce includes ~450 employees, in six sites located in four countries. We are a sister company to Sekisui Medical in Japan and in China, making us a worldwide company with R&D and Manufacturing facilities on three continents.

We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include: